Tumor angiogenesis: past, present and the near future.

By R. Kerbel. Carcinogenesis, 2000

1,027 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/2bee8be059000b5a7370f98b8581cbf4954da649

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Rakesh K. Jain
2. Peter Carmeliet
3. R. Kerbel
4. P. Bőhlen
5. G. Klement
6. J. Pollard
7. N. Ferrara
8. Dai Fukumura

In Molecular Biology

1. Rakesh K. Jain
2. Peter Carmeliet
3. J. Pollard
4. R. Kerbel
5. N. Ferrara
6. P. Bőhlen
7. G. Klement
8. H. Wildiers

In Pathology and Forensic Medicine

1. Rakesh K. Jain
2. Peter Carmeliet
3. P. Bőhlen
4. G. Klement

Citations in the corpus

• Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy (2001, background): “On the other hand, macrophages have also been found to promote tumor angiogenesis (14) and to secrete a wide range of growth factors which may promote tumor growth (15).”
• Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. (2000, background): “Intriguingly, this list may include many different conventional cytotoxic chemotherapeutic drugs (2), radiation (13), and hormonal ablation therapies (14, 15).”
• The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis (2005, background): “Indeed, both progression and patient mortality are correlated with microvascular density, which is a measure of the development of the metabolic microenvironmen”
• Vascular Endothelial Growth Factor and Angiogenesis (2004, background): “The formation of new blood vessels provides a mechanism by which an in situ tumor lesion can circumvent the critical limitations of the oxygen diffusion distance and restrictions on nutrient exchange (Folkman, 1995; Carmeliet, 2000; Carmeliet and Jain, 2000; Kerbel, 2000).”
• Angiogenesis in cancer and other diseases (2000, background): “These include metabolic stress (for example, low p O 2 , low pH or hypoglycaemia), mechanical stress (for example, pressure generated by proliferating cells), immune/inflammatory response (for example, immune/inflammatory cells that have infiltrated the tissue), and genetic mutations (for examp”